Arnaud has been awarded this FNRS grant, which enables young researchers to develop their own units. Congratulations Arnaud!

Denis Mottet's team has published an article on the molecular understanding of spinal muscular atrophy in Nature Communications, and has just been awarded by European funding (JPND) to continue their research.

Michaëls Herfs has been awarded this prize for his original and daring research project focused on cervical cancer.

The laboratories of Luc Willems (GIGA-Cancer) and Vincent Seutin (GIGA-Neurosciences) have just published a study which establishes the scientific basis of a new therapeutic strategy for Steinert’s disease. 

Pierre Close (Cancer Signaling Laboratory - GIGA Stem Cells) has been selected for his project "Demystifying what makes melanoma so good at resisting treatments" and is receiving £155,000 in funding.

This study by Akeila Bellahcène's team (Metastasis Research Laboratory) characterized an epigenomic signature of methylglyoxal that effectively discriminates triple-negative breast cancer patients with poor survival.

Michael Herfs' team (Laboratory of Experimental Pathology, GIGA-Cancer) demonstrates that, by hijacking host DNA damage/repair mechanisms, human papillomaviruses (HPV) actively contribute to the elevated radiosensitivity of virus-related cancers.

Soutenez Alice, doctorante au LBTD, cette nuit lors de la finale internationale de Ma Thèse en 180 secondes (MT180) à Montréal. Elle y expliquera son travail sur le cancer du sein en lien avec les Diables rouges !

Thanks to the Fondation Contre le Cancer, ULiège will accelerate the development of its proteomics research at the single-cell level in cancerology. This complete technological platform dedicated to "single-cell proteomics" is unique in the Wallonia-Brussels Federation.

Congratulations to all researchers obtaining a new FNRS mandate !

A collaboration between the teams of Ingrid Struman and Franck Dequiedt shows that exosomes modify the tumor environment to promote breast cancer progression.

Doctorante au GIGA-Cancer (Faculté de médecine) de l'Université de Liège, Alice Collignon représentera la Belgique lors de la finale internationale à Montréal en octobre 2022.